IS3L:XETRA:XETRA-iShares USD Ultrashort Bond UCITS (EUR)

ETF | Others |

Last Closing

USD 96.314

Change

-0.39 (-0.41)%

Market Cap

USD 0.30B

Volume

288.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.47 (+0.88%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.10 (+0.58%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.10 (+0.34%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.20 (+0.70%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.08 (+0.30%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.39 (-0.84%)

USD 102.61B
8R80:XETRA Amundi Index Solutions - Amund..

-2.60 (-1.81%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.31 (+0.59%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.24 (-0.22%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-2.82 (-0.46%)

USD 80.38B

ETFs Containing IS3L:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.73% 23% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.73% 23% F 25% F
Trailing 12 Months  
Capital Gain 3.28% 22% F 29% F
Dividend Return 5.92% 95% A 88% B+
Total Return 9.21% 41% F 44% F
Trailing 5 Years  
Capital Gain 4.98% 35% F 40% F
Dividend Return 15.39% 85% B 72% C
Total Return 20.37% 42% F 45% F
Average Annual (5 Year Horizon)  
Capital Gain 2.15% 33% F 35% F
Dividend Return 3.12% 36% F 37% F
Total Return 0.98% 69% C- 48% F
Risk Return Profile  
Volatility (Standard Deviation) 7.50% 74% C 80% B-
Risk Adjusted Return 41.66% 39% F 44% F
Market Capitalization 0.30B 54% F 48% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.